NASDAQ:CGNT', 'Cogentix Medical Inc.', 'http://kldaily.com/kl-logo.png');

Cogentix Medical Incorporated (NASDAQ:CGNT) on Focus After Report of More Shorts

December 9, 2017 - By reb123z

 Cogentix Medical Incorporated (NASDAQ:CGNT) on Focus After Report of More Shorts

The stock of Cogentix Medical Incorporated (NASDAQ:CGNT) registered an increase of 10.67% in short interest. CGNT’s total short interest was 52,900 shares in December as published by FINRA. Its up 10.67% from 47,800 shares, reported previously. With 62,200 shares average volume, it will take short sellers 1 days to cover their CGNT’s short positions. The short interest to Cogentix Medical Incorporated’s float is 0.27%.

It closed at $2.95 lastly. It is down 83.33% since December 9, 2016 and is uptrending. It has outperformed by 66.63% the S&P500.

Cogentix Medical, Inc., a medical device company, designs, develops, makes, and markets fiberoptic and video endoscopy products under the PrimeSight brand worldwide. The company has market cap of $179.67 million. The firm offers endoscopes, such as cystoscopes, laryngoscopes, transnasal esophagoscopes, and bronchoscopes for medical use; and borescopes for industrial use, as well as digital processing units for medical use. It currently has negative earnings. It also provides EndoSheath Protective Barrier, a sterile, single-use microbial barrier for use with flexible endoscopes.

Cogentix Medical, Inc. (NASDAQ:CGNT) Ratings Coverage

Among 4 analysts covering Cogentix Medical (NASDAQ:CGNT), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Cogentix Medical had 8 analyst reports since November 5, 2015 according to SRatingsIntel. The rating was downgraded by Roth Capital on Friday, May 6 to “Neutral”. The firm has “Buy” rating by Roth Capital given on Tuesday, July 18. The firm has “Buy” rating by TH Capital given on Thursday, November 5. JMP Securities initiated Cogentix Medical, Inc. (NASDAQ:CGNT) on Friday, October 6 with “Buy” rating. Roth Capital maintained the stock with “Buy” rating in Wednesday, November 8 report. The firm has “Buy” rating by Roth Capital given on Thursday, November 5. The stock of Cogentix Medical, Inc. (NASDAQ:CGNT) has “Buy” rating given on Wednesday, August 2 by Roth Capital.

More notable recent Cogentix Medical, Inc. (NASDAQ:CGNT) news were published by: Prnewswire.com which released: “Cogentix Medical Announces Palmetto GBA Extends Medicare Coverage on Urgent® PC” on December 06, 2017, also Zacks.com with their article: “Cogentix Medical (CGNT) in Focus: Stock Moves 6.6% Higher December 04, 2017” published on December 04, 2017, Prnewswire.com published: “Cogentix Medical Makes $2 Million Investment in Israeli Company Developing …” on September 28, 2017. More interesting news about Cogentix Medical, Inc. (NASDAQ:CGNT) were released by: Prnewswire.com and their article: “Cogentix Medical Reports Third Quarter Results; Second Highest Quarterly …” published on November 07, 2017 as well as Seekingalpha.com‘s news article titled: “Premarket analyst action – healthcare” with publication date: December 01, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.